Search Results - "Cleton, F J"

Supplementation with antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based chemotherapy: a randomised, double-blind, placebo-controlled study by Weijl, N.I, Elsendoorn, T.J, Lentjes, E.G.W.M, Hopman, G.D, Wipkink-Bakker, A, Zwinderman, A.H, Cleton, F.J, Osanto, S

“…Cisplatin-induced toxicities are mainly caused by the formation of free radicals, leading to oxidative organ damage. Plasma concentrations of antioxidants…”
Get full text

Free radicals and antioxidants in chemotherapy-induced toxicity by WEIJL, N. I, CLETON, F. J, OSANTO, S

Get full text

Positron-emission tomography with [18F]fluorodeoxyglucose. Part I. Biochemical uptake mechanism and its implication for clinical studies by PAUWELS, E. K. J, STURM, E. J. C, BOMBARDIERI, E, CLETON, F. J, STOKKEL, M. P. M

“…Over the past decades, Positron Emission Tomography has opened a new field of imaging. Nowadays, this technique is being used for diagnosing, staging disease…”
Get full text

Cisplatin combination chemotherapy induces a fall in plasma antioxidants of cancer patients by Weijl, N.I., Wipkink-Bakker, A., Lentjes, E.G.W.M., Berger, H.M., Cleton, F.J., Osanto, S.

“…Background: Antioxidants protect the body against cellular oxidative damage and thus some of the adverse effects induced by cisplatin and other cytostatic…”
Get full text

Palliative pamidronate treatment in patients with bone metastases from breast cancer by van Holten-Verzantvoort, A T, Kroon, H M, Bijvoet, O L, Cleton, F J, Beex, L V, Blijham, G, Hermans, J, Neijt, J P, Papapoulos, S E, Sleeboom, H P

“…An open, randomized study was performed to assess the effects of supportive pamidronate treatment on morbidity from bone metastases in breast cancer patients…”
Get more information

Vaccination of melanoma patients with an allogeneic, genetically modified interleukin 2-producing melanoma cell line by Osanto, S, Schiphorst, P P, Weijl, N I, Dijkstra, N, Van Wees, A, Brouwenstein, N, Vaessen, N, Van Krieken, J H, Hermans, J, Cleton, F J, Schrier, P I

“…Thirty-three metastatic melanoma patients were vaccinated according to a phase I-II study with an allogeneic melanoma cell line that was genetically modified…”
Get more information

Hypothyroidism during immunotherapy with interleukin-2 is associated with antithyroid antibodies and response to treatment by Weijl, N I, Van der Harst, D, Brand, A, Kooy, Y, Van Luxemburg, S, Schroder, J, Lentjes, E, Van Rood, J J, Cleton, F J, Osanto, S

“…We investigated whether the association of interleukin-2 (IL-2) with hypothyroidism is related to the presence of thyroid autoantibodies, dose of IL-2, and…”
Get more information

The prognosis of breast cancer in males. A report of 335 cases by Guinee, V F, Olsson, H, Moller, T, Shallenberger, R C, van den Blink, J W, Peter, Z, Durand, M, Dische, S, Cleton, F J, Zewuster, R

“…Because of the relative rarity of breast cancer in males, data have not been sufficient to support a definitive analysis of pertinent prognostic factors…”
Get more information

Sequential administration of recombinant human interleukin-2 and dacarbazine in metastatic melanoma: a multicenter phase II study by Stoter, G, Aamdal, S, Rodenhuis, S, Cleton, F J, Iacobelli, S, Franks, C R, Oskam, R, Shiloni, E

“…Twenty-five assessable patients with metastatic melanoma have been entered in a multicenter phase II study of two induction cycles of human recombinant…”
Get more information

The diagnostic utility of somatostatin receptor scintigraphy in oncology by VALKEMA, R, STEENS, J, CLETON, F. J, PAUWELS, E. K. J

“…Somatostatin receptor scintigraphy (SRS) with the diethylenetriaminopentaacetic-acid-conjugated somatostatin analogue [111In-DTPA-D-Phe1] octreotide, also…”
Get full text

Hypercalcemia in patients with breast cancer : a survival study by DE WIT, S, CLETON, F. J

“…In a retrospective study survival after hypercalcemia in breast cancer patients has been investigated. A group of 72 patients were treated with bisphosphonate…”
Get full text

Ifosfamide treatment as a 10-day continuous intravenous infusion by KEIZER, H. J, OUTWERKERK, J, WELVAART, K, VAN DER VELDE, C. J. H, CLETON, F. J

“…Experimental and clinical studies on ifosfamide indicate that fractionated treatment regimens have a higher efficacy compared to a single short-term infusion…”
Get full text

Thromboembolic Events During Chemotherapy for Germ Cell Cancer: A Cohort Study and Review of the Literature by Weijl, N I, Rutten, M F, Zwinderman, A H, Keizer, H J, Nooy, M A, Rosendaal, F R, Cleton, F J, Osanto, S

“…To evaluate the risk of major thromboembolic complications in male germ cell cancer patients receiving cisplatin-based chemotherapy and to review the…”
Get full text

Reduced morbidity from skeletal metastases in breast cancer patients during long-term bisphosphonate (APD) treatment by van Holten-Verzantvoort, A T, Bijvoet, O L, Cleton, F J, Hermans, J, Kroon, H M, Harinck, H I, Vermey, P, Elte, J W, Neijt, J P, Beex, L V

“…131 patients with osteolytic metastases from breast cancer were randomised to receive long-term oral treatment with aminohydroxy-propylidene-bisphosphonate…”
Get more information

Age at diagnosis as an indicator of eligibility for BRCA1 DNA testing in familial breast cancer by CORNELIS, R. S, VASEN, H. F. A, CORNELISSE, C. J, DEVILEE, P, MEIJERS-HEIJBOER, H, FORD, D, VAN VLIET, M, VAN TILBORG, A. A. G, CLETON, F. J, KLIJN, J. G. M, MENKO, F. H, MEERA KHAN, P

“…We searched for criteria that could indicate breast cancer families with a high prior probability of being caused by the breast/ovarian cancer susceptibility…”
Get full text

Reverse smoking as a risk factor for palatal cancer: a cross-sectional study in rural Andhra Pradesh, India by van der Eb, M M, Leyten, E M, Gavarasana, S, Vandenbroucke, J P, Kahn, P M, Cleton, F J

“…A cross-sectional study of reverse smoking and its association with pre-malignant and malignant lesions of the palate was conducted in the north coastal areas…”
Get more information

Does supportive pamidronate treatment prevent or delay the first manifestation of bone metastases in breast cancer patients? by van Holten-Verzantvoort, A.T.M., Hermans, J., Beex, L.V.A.M., Blijham, G., Cleton, F.J., van Eck-Smit, B.C.F., Sleeboom, H.P., Papapoulos, S.E.

“…The effect of pamidronate treatment on the first development of bone metastases was investigated in 124 patients with breast cancer, with either locally…”
Get full text

Radioimmunotherapy : no news from the newcomer by MELLO, A. M, PAUWELS, E. K. J, CLETON, F. J

Get full text

ras oncogene activation in human ovarian carcinoma by van 't Veer, L J, Hermens, R, van den Berg-Bakker, L A, Cheng, N C, Fleuren, G J, Bos, J L, Cleton, F J, Schrier, P I

“…Samples of 37 fresh human ovarian tumor biopsies were screened to detect proto-oncogene amplification and ras mutations. Three samples showed c-K-ras2…”
Get more information

Reversible neurotoxicity during interleukin-2 therapy for metastatic renal cell carcinoma by van Laar, J.M., van Buchem, M.A., Weyl, N., Cleton, F.J.

Get full text